(Q40456917)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719171%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719171%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

main subject

transmembrane protein

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719171%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Luis Galietta

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719171%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

O Zegarra-Moran

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719171%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719171%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719171%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719171%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719171%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

446-460

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719171%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00018-004-4422-3

8 January 2020

exact match

0 references

cites work

Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia

1 reference

12 December 2020

Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis

1 reference

12 December 2020

Insulin sensitivity during combined androgen blockade for prostate cancer

1 reference

12 December 2020

The heart: a novel gonadotrophin-releasing hormone target

1 reference

12 December 2020

Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor gamma-chain messenger ribonucleic acids that are regulated by GnRH in vitro

1 reference

12 December 2020

Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity

1 reference

12 December 2020

Dose-dependent effect of androgen deprivation therapy for localized prostate cancer on adverse cardiac events

1 reference

12 December 2020

Effects of the luteinizing hormone-releasing hormone agonist leuprolide on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia

1 reference

12 December 2020

Disease control outcomes from analysis of pooled individual patient data from five comparative randomised clinical trials of degarelix versus luteinising hormone-releasing hormone agonists

1 reference

12 December 2020

Testosterone protects rat hearts against ischaemic insults by enhancing the effects of alpha(1)-adrenoceptor stimulation

1 reference

12 December 2020

Testosterone: a vascular hormone in health and disease

1 reference

12 December 2020

The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action

1 reference

12 December 2020

Testosterone induces cytoprotection by activating ATP-sensitive K+ channels in the cardiac mitochondrial inner membrane

1 reference

12 December 2020

Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism

1 reference

12 December 2020

Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist

1 reference

12 December 2020

Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden

1 reference

12 December 2020

Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE(-/-) mice.

1 reference

12 December 2020

The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy.

1 reference

12 December 2020

Nontranscriptional regulation of cardiac repolarization currents by testosterone

1 reference

12 December 2020

Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study

1 reference

12 December 2020

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer

1 reference

12 December 2020

Enhanced vasoconstriction and reduced vasorelaxation induced by testosterone and nandrolone in hypercholesterolemic rabbits

1 reference

12 December 2020

Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer

1 reference

12 December 2020

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality

1 reference

12 December 2020

The effects of androgen deprivation therapy on cardiac function and heart failure: implications for management of prostate cancer

1 reference

12 December 2020

Endocrine complications of androgen-deprivation therapy in men with prostate cancer.

1 reference

12 December 2020

Androgens up-regulate atherosclerosis-related genes in macrophages from males but not females: molecular insights into gender differences in atherosclerosis

1 reference

12 December 2020

Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.

1 reference

12 December 2020

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

1 reference

12 December 2020

Androgen deprivation therapy for prostate cancer does not increase cardiovascular mortality in the long term

1 reference

12 December 2020

Cardiovascular risk with androgen deprivation therapy for prostate cancer: potential mechanisms

1 reference

12 December 2020

Impact of androgen deprivation therapy on cardiovascular disease and diabetes.

1 reference

12 December 2020

Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.

1 reference

12 December 2020

Testosterone and the cardiovascular system: a comprehensive review of the basic science literature

1 reference

12 December 2020

Testosterone diminishes the proarrhythmic effects of dofetilide in normal female rabbits

1 reference

12 December 2020

The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based study

1 reference

12 December 2020

Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages

1 reference

12 December 2020

Changes in body composition during androgen deprivation therapy for prostate cancer

1 reference

12 December 2020

Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006

1 reference

12 December 2020

Testosterone enhances early cardiac remodeling after myocardial infarction, causing rupture and degrading cardiac function

1 reference

12 December 2020

Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer

1 reference

12 December 2020

Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall

1 reference

12 December 2020

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

12 December 2020

Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome

1 reference

12 December 2020

Sex and strain differences in adult mouse cardiac repolarization: importance of androgens

1 reference

12 December 2020

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer

1 reference

12 December 2020

The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance

1 reference

12 December 2020

Androgen receptor-dependent and independent atheroprotection by testosterone in male mice

1 reference

12 December 2020

Androgen deprivation therapy for prostate cancer: implications for cardiometabolic clinical care

1 reference

12 December 2020

Expression of follicle-stimulating hormone receptor in tumor blood vessels

1 reference

12 December 2020

Effects of gonadotrophin-releasing hormone outside the hypothalamic-pituitary-reproductive axis.

1 reference

12 December 2020

RETRACTED: Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1126/SCIENCE.293.5536.1793

Identifiers

DOI

10.1007/S00018-004-4422-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15719171%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference